OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
ALMIB59

Amoeba SA

Agricultural ChemicalsVerified

Amoeba SA has a negative equity position of EUR -5.36 million and a debt-to-equity ratio of -2.28, indicating a leveraged capital structure with liabilities exceeding assets. The company's liquidity position is assessed as medium, with a current ratio of 0.98, suggesting limited short-term liquidity cushion. Operating cash flow of EUR -6.09 million and free cash flow of EUR -8.43 million indicate negative cash generation from operations. Profitability metrics show significant underperformance relative to industry norms. Return on equity of 154.86% is positive but driven by negative equity rather than earnings, while return on assets of -8.19% indicates asset underutilization. The company reported EUR -6.78 million operating income and EUR -8.30 million net income, with gross profit of EUR -631,280, reflecting operational losses. The company's revenue concentration is not disclosed in available segments, but its business model focuses on water treatment solutions for industrial and commercial clients. No specific geographic revenue breakdown is provided in the input data. Growth trajectory analysis is constrained by the absence of historical revenue data. The company reported EUR 0 revenue in the latest period, suggesting operational challenges or reporting anomalies. Analysts have assigned a mean price target of EUR 1.47 with mixed recommendations (2 strong buys, 1 hold). Key risk factors include negative net cash position after debt subtraction and significant operating losses. Dilution risk is assessed as low, with no near-term pressure indicated in the input data. No recent filings or transcripts are provided to assess material events.

30-day price · ALMIB+0.08 (+9.3%)
Low$0.81High$0.97Close$0.94As of16 May, 00:00 UTC
Profile
CompanyAmoeba SA
TickerALMIB.PA
SectorBasic Materials
BusinessChemicals
Industry groupChemicals
IndustryAgricultural Chemicals
AI analysis

Business. Amoeba SA develops, manufactures, and markets biological products for water treatment, including Cleantech biological solutions and amoebic and Legionella tests.

Classification. Amoeba SA is classified in the Basic Materials economic sector, Chemicals business sector, and Agricultural Chemicals industry with 92% confidence.

Amoeba SA has a negative equity position of EUR -5.36 million and a debt-to-equity ratio of -2.28, indicating a leveraged capital structure with liabilities exceeding assets. The company's liquidity position is assessed as medium, with a current ratio of 0.98, suggesting limited short-term liquidity cushion. Operating cash flow of EUR -6.09 million and free cash flow of EUR -8.43 million indicate negative cash generation from operations. Profitability metrics show significant underperformance relative to industry norms. Return on equity of 154.86% is positive but driven by negative equity rather than earnings, while return on assets of -8.19% indicates asset underutilization. The company reported EUR -6.78 million operating income and EUR -8.30 million net income, with gross profit of EUR -631,280, reflecting operational losses. The company's revenue concentration is not disclosed in available segments, but its business model focuses on water treatment solutions for industrial and commercial clients. No specific geographic revenue breakdown is provided in the input data. Growth trajectory analysis is constrained by the absence of historical revenue data. The company reported EUR 0 revenue in the latest period, suggesting operational challenges or reporting anomalies. Analysts have assigned a mean price target of EUR 1.47 with mixed recommendations (2 strong buys, 1 hold). Key risk factors include negative net cash position after debt subtraction and significant operating losses. Dilution risk is assessed as low, with no near-term pressure indicated in the input data. No recent filings or transcripts are provided to assess material events.
Key takeaways
  • Amoeba SA operates at a significant loss with negative equity and cash flow, indicating severe financial distress.
  • The company's debt-to-equity ratio of -2.28 suggests a highly leveraged capital structure with liabilities exceeding assets.
  • Return on equity of 154.86% is mathematically positive but driven by negative equity rather than profitability.
  • Analysts have assigned a mean price target of EUR 1.47 with mixed recommendations, reflecting uncertainty about the company's value proposition.
  • The company's water treatment solutions represent a niche market opportunity but face significant operational and financial challenges.
  • # RATIONALES
  • {
  • "margin_outlook_rationale": "Operating margin is expected to remain negative due to persistent operating losses and lack of revenue visibility.",
Financial snapshot
PeriodHA-latest
CurrencyEUR
Revenue$0.00
Gross profit-$631.3k
Operating income-$6.8M
Net income-$8.3M
R&D
SG&A
D&A
SBC
Operating cash flow-$6.1M
CapEx-$1.3M
Free cash flow-$8.4M
Total assets$10.1M
Total liabilities$15.5M
Total equity-$5.4M
Cash & equivalents
Long-term debt$12.2M
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY0
FY-1
FY-2
FY-3
FY-4
PeriodGross %Op %Net %FCF %
FY0
FY-1
FY-2
FY-3
FY-4
PeriodAssetsEquityCashDebt
FY0
FY-1
FY-2
FY-3
FY-4
PeriodOCFCapExFCFSBC
FY0
FY-1
FY-2
FY-3
FY-4
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodGross %Op %Net %FCF %
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodAssetsEquityCashDebt
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodOCFCapExFCFSBC
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book-$5.4M
Net cash-$12.2M
Current ratio1.0
Debt/Equity-2.3
ROA-82.0%
ROE1.5%
Cash conversion73.0%
CapEx/Revenue
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Chemicals · cohort 11 companies
MetricALMIBActivity
Op margin0.4% medp25 -8.0% · p75 16.0%
Net margin2.3% medp25 -11.6% · p75 11.8%
Gross margin20.8% medp25 14.9% · p75 24.0%
R&D / revenue1.1% medp25 0.5% · p75 1.3%
CapEx / revenue6.2% medp25 5.4% · p75 10.2%
Debt / equity-228.0%59.0% medp25 54.9% · p75 72.9%bottom quartile
Observations
IR observations
Mean price target1.47 EUR
Median price target1.40 EUR
High price target1.90 EUR
Low price target1.10 EUR
Mean recommendation1.67 (1=strong buy, 5=strong sell)
Strong-buy count2.00
Buy count0.00
Hold count1.00
Sell count0.00
Strong-sell count0.00
Mean EPS estimate-0.11 EUR
Last actual EPS-0.14 EUR
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-10 07:35 UTC#c54a52ab
Market quoteclose EUR 0.87 · shares 0.07B diluted
no public URL
2026-05-05 20:04 UTC#3e05ed5f
Source: analysis-pipeline (hybrid)Generated: 2026-05-10 07:37 UTCJob: 37091998